Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

被引：0
|
作者：
Andrea Camerini
Cheti Puccetti
Sara Donati
Chiara Valsuani
Maria Cristina Petrella
Gianna Tartarelli
Paolo Puccinelli
Domenico Amoroso
机构：
[1] Versilia Hospital and Istituto Toscano Tumori,Medical Oncology
来源：
BMC Cancer | / 15卷
关键词：
Elderly; Non-small-cell lung cancer; Metronomic vinorelbine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Docetaxel and Oxaliplatin as First-Line Therapy for Advanced Non-Small Cell Lung Cancer: A Phase II Trial
    Radhakrishnan, A.
    Bitran, J. D.
    Milton, D. T.
    Tolzien, K.
    Hallmeyer, S.
    Nabhan, C.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (04) : 439 - 444
  • [22] Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
    Farhat, Fadi S.
    Ghosn, Marwan G.
    Kattan, Joseph G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 235 - 242
  • [23] Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
    Fadi S. Farhat
    Marwan G. Ghosn
    Joseph G. Kattan
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 235 - 242
  • [24] Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Neubauer, MA
    Garfield, DH
    Kuerfler, PR
    Raju, RN
    Lindquist, DL
    Soo, EW
    Khan, M
    Boehm, KA
    Asmar, L
    LUNG CANCER, 2005, 47 (01) : 121 - 127
  • [25] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Sujith Kalmadi
    Giles McNeill
    Mellar Davis
    David Peereboom
    David Adelstein
    Tarek Mekhail
    Medical Oncology, 2006, 23 : 507 - 513
  • [26] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Kalmadi, Sujith
    McNeill, Giles
    Davis, Mellar
    Peereboom, David
    Adelstein, David
    Mekhail, Tarek
    MEDICAL ONCOLOGY, 2006, 23 (04) : 507 - 513
  • [27] A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer
    Riedel, Richard F.
    Andrews, Carolyn
    Garst, Jennifer
    Dunphy, Frank
    Herndon, James E.
    Blackwell, Susan
    Barbour, Sally
    Crawford, Jeffrey
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : 520 - 525
  • [28] Preliminary efficacy and safety of camrelizumab plus metronomic oral vinorelbine as first-line therapy for people aged 70 and above with advanced non-small cell lung cancer (NSCLC) from a phase II trial
    Li, Lin
    Zhang, Ping
    Gao, Jiayi
    Tang, Min
    Nie, Xin
    Ma, Di
    Zhao, Zhe
    Yuan, Yue
    Ding, Li
    Li, Chao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Shipley, Dianna L.
    Ervin, Thomas J.
    Kohler, Peter C.
    Lubiner, Eric T.
    Peyton, James D.
    Waterhouse, David M.
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 196 - 202
  • [30] Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer
    Grunberg, SM
    Dugan, MC
    Greenblatt, MS
    Ospina, DJ
    Valentine, JW
    CANCER INVESTIGATION, 2005, 23 (05) : 392 - 398
12345